Once again, RISE Nashville delivered rich content, deep discussions, and fantastic networking. The conference was bigger than ever with roughly 1,400 attendees. Risk adjustment and quality improvement were the focus topics for about 50% of the conference attendees coming from payers, providers, health systems, and technology vendors.
RISE reached new heights, kicking off the conference with John Medina, a developmental molecular biologist with a lifelong fascination with how the mind reacts to and organizes information, as the keynote. He presented fascinating research on the human brain, the impacts of aging, socialization, diet, and ways to optimize its performance. His delivery was on point, energetic, and focused on social determinants of health leaving you with wanting more; which is why I bought John’s book, “Brain Rules” from Amazon before the session ended. Kudos, John!
This year, RISE had five subject tracks covering topics from the traditional risk adjustment & analytics, which is the core of the conference, to regulation, cyber security, and data inundation. The discussions were led by some of the industry’s best and brightest who shared insights illustrating good, better, and best practices to make an impact on the members they serve. Although some panel discussions morphed into infomercials straying from RISE’s objective, they’re still delivering nuggets of wisdom. If you were reading between the lines you found leading payers who not only partnered and implemented new technologies, but also made big changes to traditional processes to exceed revenue targets while improving compliance and delivering on operational efficiency.
RISE perfected networking opportunities by improving the flow of attendees through the exhibit hall. The conference provided not only the framework to meet the industry’s innovators, but also a forum for new partnerships and strategic alliances.
On the technology front, the promise of AI was prevalent. Many of the technology players discussed AI broadly, interchanging (or confusing) terminology such as machine learning, natural language processing, and analytics. By the end of the conference it was clear that AI had stolen the hearts and minds of the attendees. The challenge for healthcare leaders will be the application of emerging technology into mature risk and quality processes, reshaping the way we use available data to gain insight, target, engage, deliver better care, and improve outcomes – all at a lower cost.
Between sessions, networking, and personal conversations, it was clear that payers were looking for a breakthrough in the application of technology to make sense of the growing volume of data they have, and more importantly, to find innovative ways to close information gaps that exist in their processes. Although AI is in its infancy within healthcare, it is a technology that payers are rapidly embracing and are willing to make strategic investments in to better position their organizations for the future.
In the coming weeks, we’ll help you discern between innovators and disruptors to deliver on the promise of AI. In the meantime, if you have any questions about the role of AI or how Prognos unlocks the value of lab data for care management, risk, and quality operations, contact us to talk to one of our experts.